Drug Discovery

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

Drug repurposing is in vogue, but it’s not always as easy as you think.

Could harnessing the power of artificial intelligence put an end to the leading cause of sight loss in the developed world?

Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?

Why are spherical nucleic acids so exciting for drug development?

Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.

Could aquatic bacteria hold the keys to bolstering our drug pipelines?

Sitting Down With… Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, US.

Researchers at the University of California, San Francisco have developed a virtual library of commercially available chemical compounds.